Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Mileshkin

Showing results (71-80 of 174) with videos related to

Pageof 18
Sort By:
Lung Cancer (Amsterdam, Netherlands)|December 24, 2013
Low physical activity levels and functional decline in individuals with lung cancerCatherine L Granger, Christine F McDonald, Louis Irving, et al.
BJU International|October 30, 2018
The trajectory of patients who die from metastatic prostate cancer: a population-based studyAnna Collins, Vijaya Sundararajan, Jeremy Millar, et al.
Pathology|December 9, 2014
Development and validation of a gene expression tumour classifier for cancer of unknown primaryRichard W Tothill, Fan Shi, Lisa Paiman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 16, 2015
¹⁸F-FDG PET/CT following chemoradiation of uterine cervix cancer provides powerful prognostic stratification independent of HPV status: a prospective cohort of 105 women with mature survival dataShankar Siva, Siddhartha Deb, Richard J Young, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2015
The Cervix Cancer Research Network: A Global Outreach Effort on Behalf of the Gynecologic Cancer InterGroupDavid K Gaffney, Gita Suneja, Sang Young Ryu, et al.
Integrative Cancer Therapies|January 20, 2022
ENhAncing Lifestyle Behaviors in EndometriaL CancEr (ENABLE): A Pilot Randomized Controlled TrialLara Edbrooke, Pearly Khaw, Alison Freimund, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 24, 2022
Treatment patterns after poly-ADP ribose polymerase (PARP) inhibitors in epithelial ovarian cancer patientsTharani Sivakumaran, Michael Krasovitsky, Alison Freimund, et al.
Internal Medicine Journal|January 20, 2017
Perceptions of cancer of unknown primary site: a national survey of Australian medical oncologistsChristos S Karapetis, Lisa Guccione, Martin H N Tattersall, et al.
Gynecologic Oncology|February 27, 2021
REZOLVE (ANZGOG-1101): A phase 2 trial of intraperitoneal bevacizumab to treat symptomatic ascites in patients with chemotherapy-resistant, epithelial ovarian cancerKatrin M Sjoquist, David Espinoza, Linda Mileshkin, et al.
Journal of Pain and Symptom Management|April 3, 2018
Transition Points for the Routine Integration of Palliative Care in Patients With Advanced CancerAnna Collins, Vijaya Sundararajan, Jodie Burchell, et al.
Pageof 18

Showing results (71-80 of 174) with videos related to

Sort By:
Pageof 18
Lung Cancer (Amsterdam, Netherlands)|December 24, 2013
Low physical activity levels and functional decline in individuals with lung cancerCatherine L Granger, Christine F McDonald, Louis Irving, et al.
BJU International|October 30, 2018
The trajectory of patients who die from metastatic prostate cancer: a population-based studyAnna Collins, Vijaya Sundararajan, Jeremy Millar, et al.
Pathology|December 9, 2014
Development and validation of a gene expression tumour classifier for cancer of unknown primaryRichard W Tothill, Fan Shi, Lisa Paiman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 16, 2015
¹⁸F-FDG PET/CT following chemoradiation of uterine cervix cancer provides powerful prognostic stratification independent of HPV status: a prospective cohort of 105 women with mature survival dataShankar Siva, Siddhartha Deb, Richard J Young, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2015
The Cervix Cancer Research Network: A Global Outreach Effort on Behalf of the Gynecologic Cancer InterGroupDavid K Gaffney, Gita Suneja, Sang Young Ryu, et al.
Integrative Cancer Therapies|January 20, 2022
ENhAncing Lifestyle Behaviors in EndometriaL CancEr (ENABLE): A Pilot Randomized Controlled TrialLara Edbrooke, Pearly Khaw, Alison Freimund, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 24, 2022
Treatment patterns after poly-ADP ribose polymerase (PARP) inhibitors in epithelial ovarian cancer patientsTharani Sivakumaran, Michael Krasovitsky, Alison Freimund, et al.
Internal Medicine Journal|January 20, 2017
Perceptions of cancer of unknown primary site: a national survey of Australian medical oncologistsChristos S Karapetis, Lisa Guccione, Martin H N Tattersall, et al.
Gynecologic Oncology|February 27, 2021
REZOLVE (ANZGOG-1101): A phase 2 trial of intraperitoneal bevacizumab to treat symptomatic ascites in patients with chemotherapy-resistant, epithelial ovarian cancerKatrin M Sjoquist, David Espinoza, Linda Mileshkin, et al.
Journal of Pain and Symptom Management|April 3, 2018
Transition Points for the Routine Integration of Palliative Care in Patients With Advanced CancerAnna Collins, Vijaya Sundararajan, Jodie Burchell, et al.
Pageof 18